BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 11877377)

  • 21. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
    Taylor AM; Groom A; Byrd PJ
    DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDC1 is required for the intra-S-phase DNA damage checkpoint.
    Goldberg M; Stucki M; Falck J; D'Amours D; Rahman D; Pappin D; Bartek J; Jackson SP
    Nature; 2003 Feb; 421(6926):952-6. PubMed ID: 12607003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ATM-dependent DNA damage signaling pathway.
    Kitagawa R; Kastan MB
    Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage.
    Mochan TA; Venere M; DiTullio RA; Halazonetis TD
    Cancer Res; 2003 Dec; 63(24):8586-91. PubMed ID: 14695167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATM-dependent CHK2 activation induced by anticancer agent, irofulven.
    Wang J; Wiltshire T; Wang Y; Mikell C; Burks J; Cunningham C; Van Laar ES; Waters SJ; Reed E; Wang W
    J Biol Chem; 2004 Sep; 279(38):39584-92. PubMed ID: 15269203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
    Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
    Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATR regulates hexavalent chromium-induced S-phase checkpoint through phosphorylation of SMC1.
    Wakeman TP; Xu B
    Mutat Res; 2006 Nov; 610(1-2):14-20. PubMed ID: 16876463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.
    Ho GP; Margossian S; Taniguchi T; D'Andrea AD
    Mol Cell Biol; 2006 Sep; 26(18):7005-15. PubMed ID: 16943440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A murine model of Nijmegen breakage syndrome.
    Williams BR; Mirzoeva OK; Morgan WF; Lin J; Dunnick W; Petrini JH
    Curr Biol; 2002 Apr; 12(8):648-53. PubMed ID: 11967151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle regulated and is required for G(1)/S checkpoint activation in response to DNA damage.
    Post S; Weng YC; Cimprich K; Chen LB; Xu Y; Lee EY
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13102-7. PubMed ID: 11687627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint.
    Silverman J; Takai H; Buonomo SB; Eisenhaber F; de Lange T
    Genes Dev; 2004 Sep; 18(17):2108-19. PubMed ID: 15342490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.
    Pichierri P; Rosselli F
    EMBO J; 2004 Mar; 23(5):1178-87. PubMed ID: 14988723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
    Jin J; Ang XL; Ye X; Livingstone M; Harper JW
    J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models.
    Difilippantonio S; Celeste A; Fernandez-Capetillo O; Chen HT; Reina San Martin B; Van Laethem F; Yang YP; Petukhova GV; Eckhaus M; Feigenbaum L; Manova K; Kruhlak M; Camerini-Otero RD; Sharan S; Nussenzweig M; Nussenzweig A
    Nat Cell Biol; 2005 Jul; 7(7):675-85. PubMed ID: 15965469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
    Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
    Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of NBS1 in the modulation of PIKK family proteins ATM and ATR in the cellular response to DNA damage.
    Zhou J; Lim CU; Li JJ; Cai L; Zhang Y
    Cancer Lett; 2006 Nov; 243(1):9-15. PubMed ID: 16530324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity.
    Cariveau MJ; Tang X; Cui XL; Xu B
    Mol Pharmacol; 2007 Aug; 72(2):320-6. PubMed ID: 17507690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct domains in Nbs1 regulate irradiation-induced checkpoints and apoptosis.
    Difilippantonio S; Celeste A; Kruhlak MJ; Lee Y; Difilippantonio MJ; Feigenbaum L; Jackson SP; McKinnon PJ; Nussenzweig A
    J Exp Med; 2007 May; 204(5):1003-11. PubMed ID: 17485521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point mutation at the Nbs1 Threonine 278 site does not affect mouse development, but compromises the Chk2 and Smc1 phosphorylation after DNA damage.
    Li T; Wang ZQ
    Mech Ageing Dev; 2011 Aug; 132(8-9):382-8. PubMed ID: 21664921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.